Dexmedetomidine for treating agitation associated with schizophrenia [TSID10726]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Severe mental illness guidance reviewStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC
Xanomeline tartrate–trospium chloride for treating schizophrenia ID6716Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 26 June 2026Expected publication date: TBC